137 related articles for article (PubMed ID: 19949926)
21. The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases.
Thuerauf N; Fromm MF
Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):281-6. PubMed ID: 16783494
[TBL] [Abstract][Full Text] [Related]
22. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.
Li Y; Lu J; Paxton JW
Curr Drug Metab; 2012 Jun; 13(5):624-39. PubMed ID: 22475331
[TBL] [Abstract][Full Text] [Related]
23. Role of P-glycoprotein in pharmacokinetics: clinical implications.
Lin JH; Yamazaki M
Clin Pharmacokinet; 2003; 42(1):59-98. PubMed ID: 12489979
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
Fromm MF
Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein expression and pharmacological modulation in larval stages of Echinococcus granulosus.
Nicolao MC; Denegri GM; Cárcamo JG; Cumino AC
Parasitol Int; 2014 Feb; 63(1):1-8. PubMed ID: 24120508
[TBL] [Abstract][Full Text] [Related]
26. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
Döring B; Petzinger E
Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
[TBL] [Abstract][Full Text] [Related]
27. Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney.
Mahmood B; Daood MJ; Hart C; Hansen TW; Watchko JF
J Investig Med; 2001 May; 49(3):250-7. PubMed ID: 11352182
[TBL] [Abstract][Full Text] [Related]
28. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.
Chan LM; Lowes S; Hirst BH
Eur J Pharm Sci; 2004 Jan; 21(1):25-51. PubMed ID: 14706810
[TBL] [Abstract][Full Text] [Related]
29. Transporter-mediated drug-drug interactions.
Zhang L; Huang SM; Lesko LJ
Clin Pharmacol Ther; 2011 Apr; 89(4):481-4. PubMed ID: 21423238
[TBL] [Abstract][Full Text] [Related]
30. Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood-brain barrier.
Hashimoto Y; Michiba K; Maeda K; Kusuhara H
J Pharmacol Sci; 2022 Jan; 148(1):142-151. PubMed ID: 34924119
[TBL] [Abstract][Full Text] [Related]
31. [THE SYSTEM OF XENOBIOTICS BIOTRANSFORMATION OF HELMINTHS. RESEMBLANCE AND DIFFERENSES FROM SIMILAR HOST SYSTEMS (REWEW)].
Smirnov LP; Borvinskaya EV; Suhovskaya IV
Parazitologiia; 2016; 50(6):432-45. PubMed ID: 29215225
[TBL] [Abstract][Full Text] [Related]
32. Importance of P-glycoprotein for drug disposition in humans.
Fromm MF
Eur J Clin Invest; 2003 Nov; 33 Suppl 2():6-9. PubMed ID: 14641550
[TBL] [Abstract][Full Text] [Related]
33. Membrane Transporters in Physiological Barriers of Pharmacological Importance.
Nagy I; Tóth B; Gáborik Z; Erdo F; Krajcsi P
Curr Pharm Des; 2016; 22(35):5347-5372. PubMed ID: 27464727
[TBL] [Abstract][Full Text] [Related]
34. Biological barriers, and the influence of protein binding on the passage of drugs across them.
Wanat K
Mol Biol Rep; 2020 Apr; 47(4):3221-3231. PubMed ID: 32140957
[TBL] [Abstract][Full Text] [Related]
35. Xenobiotic transporter expression along the male genital tract.
Klein DM; Wright SH; Cherrington NJ
Reprod Toxicol; 2014 Aug; 47():1-8. PubMed ID: 24814985
[TBL] [Abstract][Full Text] [Related]
36. [The role of changes in the functional activity and the amount of p-glycoprotein in drug pharmacokinetics].
Ramenskaia GV; Faĭnshteĭn SL; Sychev DA
Eksp Klin Farmakol; 2007; 70(1):72-80. PubMed ID: 17402598
[TBL] [Abstract][Full Text] [Related]
37. [P-glycoprotein: structure, physiological role and molecular mechanisms of modulation functional activity].
Iakusheva EN; Chernykh IV; Shchul'kin AV; Popova NM
Usp Fiziol Nauk; 2014; 45(4):89-98. PubMed ID: 25729846
[TBL] [Abstract][Full Text] [Related]
38. Regulation of drug transporters during infection and inflammation.
Petrovic V; Teng S; Piquette-Miller M
Mol Interv; 2007 Apr; 7(2):99-111. PubMed ID: 17468390
[TBL] [Abstract][Full Text] [Related]
39. Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics.
Bajaj P; Chowdhury SK; Yucha R; Kelly EJ; Xiao G
Drug Metab Dispos; 2018 Nov; 46(11):1692-1702. PubMed ID: 30076203
[TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.
Ahmed Juvale II; Abdul Hamid AA; Abd Halim KB; Che Has AT
Heliyon; 2022 Jun; 8(6):e09777. PubMed ID: 35789865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
